Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bausch + Lomb appoints Merck's Alex Kelly VP

This article was originally published in Clinica

Executive Summary

Global eye health company Bausch & Lomb has appointed Alex Kelly vice-president of investor relations, reporting to president and CFO Bob Bertolini. Kelly joins the company from Merck & Co, where he most recently served as vice-president of investor relations. Prior to Merck he was group vice-president of global communications and investor relations at Schering-Plough.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100375

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel